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The brain microvessel endothelial cells (BMVEC) that form the blood-brain
barrier are uniquely positioned to in¯uence immune responses within the
central nervous system. As the biological interface separating the blood from
the brain extracellular ¯uid, BMVEC regulate the entry of leukocytes into the
brain. In addition, through the release of various soluble factors that affect
immuneresponses,BMVECmaymodulateimmuneresponsesinthebrain.This
reviewaddressestheinterplaybetweentheimmunesystemandtheblood-brain
barrier as it relates to the regulation of CNS defense and immunity.
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Introduction
The brain has often been considered an immunolo-
gically privileged organ. This was based on early
studies that found few antigen-presenting cells in
the central nervous system. In addition, there was a
perceived lack of a lymphatic system within the
brain to carry immunogenic material in the central
nervous system to lymph nodes where a humoral
immune response could be initiated. And ®nally,
the presence of the blood-brain barrier (BBB) was
thought to prevent the entry of immune cells from
the peripheral circulation into the brain.
However, there is increasing evidence to suggest
that the brain is under immunological surveillance
(see reviews by Cserr and Knopf, 1992; Hickey,
1999). First, the glial cells within the brain can
secrete cytokines and chemokines as well as
participate in antigen presentation (Ransohoff and
Tani, 1998; O'Keefe et al, 1999). Furthermore, the
failure of most long term central nervous system
xenografts are the result of immune responses
within the brain (Czech et al, 1997). From a disease
perspective, multiple sclerosis (MS) and experi-
mental allergic encephalomyelitis (EAE) clearly
demonstrate the devastation brought about by
cellular and humoral immune responses within
the central nervous system.
The BBB was once considered to be a physical,
static barrier to the passage of solutes and macro-
molecules from the bloodstream to the brain
extracellular ¯uid. However, recent studies indicate
the BMVEC of the BBB form a dynamic interface
between the blood and the brain that can be
in¯uenced by drug regimens (Bartus et al, 1996;
Greig, 1989) and endogenous factors such as
bradykinin (Hurst and Clark, 1998) bile salts
(Greenwood et al, 1991) and cytokines (Mark and
Miller, 1999). Changes in BBB function are ob-
served in several neurological disorders associated
with immune responses (i.e. MS, meningitis, HIV-1-
associated dementia) (Sharief et al, 1993; Speller-
berg and Tuomanen, 1994; Epstein, 1998; Power
and Johnson, 1995). The alterations in BBB function
observed in the above neurological disorders result
in a loss of integrity and enhanced permeability of
the BMVEC. The extent to which BBB permeability
is increased in neurological disorders such as MS
and meningitis is positively correlated with the
severity of the disease (Sharief et al, 1993; Speller-
berg and Tuomanen, 1994). Therefore, understand-
ing the interactions of the immune system with the
BBB during both health and disease may provide
insight into the treatment of various neurological
diseases.
This review examines the interplay between the
immune response and the BBB. Special emphasis
will be given to examining leukocyte adherence to
and penetration through the BBB. Although there
are several types of leukocytes, the present review
will focus on the neutrophils, monocytes and
lymphocytes (T and B cells) and their movement
across the BBB. In addition, the review will
consider how the BBB can in¯uence immune
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1999 Journal of NeuroVirology, Inc.responses within the central nervous system by
controlling the entry of immunomodulatory agents
into the brain. In this regard, the BBB will be treated
as both a target site for the immune system, and a
conduit for activation of immune responses within
the central nervous system.
Components of the BBB
The schematic in Figure 1 compares the capillaries
in the peripheral vasculature to those that form the
BBB. In contrast to many of the endothelial cells
found in the peripheral microvasculature, the
BMVEC form a continuous layer of cells and
extracellular matrix (Audus et al, 1992; Broadwell,
1989). There are also no detectable fenestrations
and reduced levels of pinocytic activity in the
BMVEC that form the BBB compared to endothe-
lial cells in the peripheral microvasculature
(Audus et al, 1992; Broadwell, 1989). In addition,
the brain microvessel endothelial cells also form
tight extracellular junctions, similar (but not
identical) to those found in epithelial cells
(Schneeberger and Lynch, 1984; Brightman, 1989).
Together, these morphological features act to limit
the passage of solutes, macromolecules and cells
across the BBB.
Astrocytes are an additional cellular component
of the BBB. The astrocytes are a type of glial cell
that extend foot-like projections around the out-
side of the capillaries (see Figure 1). While the
astrocytes themselves do not form the barrier,
they do have an important role in the develop-
ment and maintenance of the BBB (Goldstein,
1988). The importance of the astrocytes to the
establishment of the BBB comes from the seminal
work of Stewart and Wiley (1981). In these
studies, the embryonic, avascular quail brain was
implanted into the abdominal cavity of a chick
embryo. Although the resulting microvasculature
in the implanted quail brain originated from the
systemic abdominal vasculature of the chick,
distinct functional, morphological and biochem-
ical features emerged characteristic of the BBB.
These studies indicated that endothelial cells
placed in the microenvironment of the brain,
develop the characteristics of the brain micro-
vessels that form the BBB (Stewart and Wiley,
1981).
Direct evidence also exists that con®rms the
importance of the astrocytes in in¯uencing the
barrier properties of brain endothelial cells. These
are through the use of astrocyte co-culture and
astrocyte conditioned media in cell culture models
of the BBB (Rubin et al, 1991; Raub et al, 1992;
Hurwitz et al, 1993; Rist et al, 1997; Hayashi et al,
1997). In these models, astrocytes were either
grown on the underside of a semi-permeable
membrane with the endothelial cells cultured on
the opposite side of the membrane, or media was
collected from astrocytes and then used in the
media provided to the endothelial cells. The use of
astrocyte co-culture and conditioned media have
been reported to reduce the permeability of the
BMVEC (Rubin et al, 1991; Raub et al, 1992; Rist et
al, 1997). Even endothelial cells from the periph-
eral microvasculature (i.e. umbilical vein endothe-
lial cells) displayed reduced permeability and
BBB-speci®c characteristics following co-culture
with astrocytes (Hurwitz et al, 1993; Hayashi et al,
1997). Identi®cation of the astrocyte-released
Figure 1 Cross-sectional diagram comparing brain capillary and peripheral capillary. Signi®cant differences include the presence of
tight junctions, reduced pinocytic vesicles, increased mitochondria organelles and the close association to astrocytes in the brain
capillary.
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properties of the brain endothelial cells, as well as
the cellular mechanisms responsible for such
permeability changes, remain unknown. However,
it is clear that the astrocytes can in¯uence the
permeability characteristics of the BMVEC that
form the BBB.
In addition to the effects of astrocytes on BMVEC
permeability, it has also been suggested that the
astrocytes may in¯uence the expression of adhesion
molecules in the brain microvessel endothelial cells
that form the BBB (Engelhardt et al, 1997). Studies
by Joseph and colleagues (1997), demonstrated an
increased adhesion of T cells to both brain and
peripheral endothelia cells following exposure to
astrocyte conditioned media. In this regard, the co-
culturing of human brain microvessel endothelial
cells with human astrocytes may offer a more
representative model for examining immune re-
sponses in the BBB.
Although they occur less frequently than the
astrocytes, pericytes and perivascular cells can also
be found scattered along the length of the brain
capillary endothelial cells. The pericytes are
smooth muscle cells that are in close proximity to
the BMVEC (see Figure 1). Although the function of
the pericytes in the BBB are still being debated,
these cells produce and secrete several immuno-
modulating agents that can in¯uence immune
responses in the CNS (Fabry et al, 1993). The
pericytes may also provide a means for contraction
of the brain capillaries. Perivascular cells are
distinct from the smooth muscle derived pericytes.
The perivascular cells are also believed to have an
immune function in the CNS (Angelov et al, 1998).
Studies suggest the perivascular cells, located near
the basal lamina of the BMVEC, can act as
macrophages capable of phagocytosis and antigen
presentation (Angelov et al, 1998). Given the
proposed function of these cells and their proximity
to the brain capillaries, the cerebral perivascular
cells may provide a ®rst defense to in®ltrating
antigens in the CNS.
Role of the blood-brain barrier in traf®cking of
immune cells
The perceived inability of bone marrow derived
cells to access the brain during steady-state
conditions lead to the notion that the brain was
sequestered from the immune system by the BBB.
However, more recent studies have demonstrated
that various immune cells in the CNS, most notably,
activated monocytes, lymphocytes and B cells, can
cross the BBB (Andersson et al, 1992; Nottet et al,
1996; Hickey et al, 1991; Knopf et al, 1998). Such
studies have necessitated a re-thinking of the role of
the BBB in immune cell traf®cking into the central
nervous system.
Monocyte and neutrophil traf®cking across the BBB
An important part of the body's defense of
bacterial or viral infections is the ability of
monocytes and neutrophils to invade the tissue
and begin phagocytosis of the foreign material.
Indeed, in®ltration of the monocytes and neutro-
phils from the bloodstream into the infected tissue
is part of the initial immune response. However,
there are notable differences in the penetration of
monocytes and neutrophils in the BBB and the
peripheral microvasculature. First, traf®cking of
activated leukocytes across the BBB display
differences that are dependent on cell type, with
monocytes being more capable than neutrophils in
moving through the BBB. This was demonstrated
in mice injected with various pro-in¯ammatory
stimuli directly into the hippocampus (Andersson
et al, 1991, 1992). Under normal homeostatic
conditions, there was minimal margination and
diapedisis of neutrophils and monocytes observed
in the BBB. Following hippocampal injection of
kianic acid or LPS challenge, a dramatic increase
in the margination of neutrophils and monocytes
to the BMVEC was seen (Andersson et al, 1991,
1992). Although there was an increased attach-
ment of both neutrophils and monocytes to the
BMVEC, only the monocytes underwent diapedisis
and were able to move through the BBB into the
brain. In®ltration of neutrophils through the BBB
was only observed following breakdown of BBB
integrity, and was in contrast to the rapid and
substantial accumulation of neutrophils observed
in the CSF through the choriod plexus (Andersson
et al, 1991, 1992). The relative inability of
neutrophils to move across the BBB, suggests that
it is the initial monocyte response that is an
important mediator of the immune response in the
CNS.
Additional evidence in support of monocyte
movement across the BBB can be found in the
studies of Persidsky and colleagues (1997) and Fiala
and co-workers (1997) examing the passage of the
normal and stimulated monocytes across an in vitro
model of the BBB. In these studies, the migration of
HIV-infected monocytes was examined in a BBB
model consisting of co-cultured BMVEC and astro-
cytes. As was observed in vivo,f e wm o n o c y t e sw e r e
able to migrate across the BMVEC monolayer under
normal conditions (Persidsky et al, 1997; Fiala et al,
1997). However, following activation of the mono-
cytes with pro-in¯ammatory mediators such as LPS
or tumor necrosis factor, signi®cant increases in
monocyte migration across the brain microvessel
endothelial monolayers was observed (increases of
up to 20-fold over control monolayers). Interest-
ingly, there was no difference between HIV-infected
or control (uninfected) monocyte migration across
this BBB model, suggesting it is the generalized
activation state of the monocyte that is important for
penetrating the BBB.
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cytes versus neutrophils in the in vitro BMVEC
culture model has also recently been observed (Gan
et al, 1999). In these studies the adhesion and
migration of neutrophils and monocytes were
examined in human BMVEC co-cultured with
astrocytes. Following exposure of the monolayers
to cocaine, there was an increase in adherence of
both neutrophils and monocytes to the brain
m i c r o v e s s e le n d o t h e l i a lc e l l s .C o n s i s t e n tw i t ht h e
in vivo studies, while both neutrophils and mono-
cytes attached to the brain endothelial cells, only
the monocytes exhibited signi®cant migration
across the endothelial cell monolayers (Gan et al,
1999).
These studies are in contrast to the early reports
demonstrating signi®cant adherence and migration
of neutrophils across cultured bovine BMVEC
monolayers (Dorovini-Zis et al, 1992). However, it
should be noted that neutrophil migration was
signi®cantly increased in these studies through the
use of speci®c chemotactic gradients produced by
formyl-methionyl-leucyl phenylalanine, leuko-
triene B4 or acetyl-glyceryl-ether-phosphorylcho-
line. Such studies suggest that the activity of the
monocyte migration observed in vivo may not be a
function of the brain endothelial cells, but rather,
the chemotactic agents presented in or around the
CNS.
T h et i m ec o u r s er e q u i r e df o rt h ei n ® l t r a t i o no f
monocytes and neutrophils into the CNS is also
different from peripheral tissues. Following an
in¯ammatory response outside the brain, there is
a rapid in®ltration of neutrophils and monocytes
that occurs within minutes of the in¯ammatory
stimulus. Peak migration rates for neutrophils and
monocytes outside the brain typically occur
within 4 h (Cybulsky et al, 1988). This is in stark
contrast to the time course of in®ltration observed
in the CNS following acute in¯ammatory re-
sponses. Following direct injection of LPS into
the parenchyma of the central nervous system of
mice, Andersson and colleagues (1992) observed
a delayed appearance of macrophages in the
brain. In these studies there was no signi®cant
migration of monocytes into the brain parenchy-
ma until 2 days post LPS injection in the
hippocampus. While there was a signi®cant
increase in the number of macrophages in the
brain 2 days after LPS stimulus, the number of
macrophages were signi®cantly less than ob-
served in non-CNS tissue following LPS challenge
(Andersson et al, 1992). The observation that the
number of macrophage cells in the brain (follow-
ing LPS injection) was reduced when peripheral
circulating monocytes were depleted, suggests
that a signi®cant number of the macrophages in
the brain parenchyma were attributable to the
in®ltration of monocytes across the BBB (Anders-
son et al, 1992). These studies indicate that the
time course for entry of the monocytes into the
brain is signi®cantly delayed compared to other
tissues outside the BBB.
Lymphocyte traf®cking across the BBB
Under normal conditions, there are minimal num-
bers of lymphocytes detected within the CNS
(Hauser et al., 1983; Hickey et al, 1991; Hickey
and Kimura, 1987). This is the result of reduced
penetration of lymphocytes across the BMVEC and
the low levels of major histocompatibility complex
expression in the normal CNS (Wong et al, 1984).
However, during in¯ammatory conditions such as
viral, bacterial or parasitic infections in the CNS,
there is a signi®cant accumulation of lymphocytes
in the brain.
The ability of T lymphocytes to penetrate the BBB
is illustrated in the studies of Hickey and colleagues
(1991). In these studies, the penetration of T
lymphocytes were examined in rat brain. The
®ndings of these studies were that non-activated T
lymphocytes had a minimal penetration into the
CNS. However, activated T lymphocytes (i.e.
lymphoblasts) were quite capable of penetrating
the BBB (Hickey et al, 1991). The activated T
lymphocytes crossed the BBB in a random fashion,
and were not in¯uenced by the speci®c antigen,
major histocompatibility compatability, or pheno-
type of the T cell. Passage into the CNS occurred
over a period of hours and, unless the speci®c
antigen was recognized, the T lymphocytes exited
the CNS within 24±48 h (Hickey et al,1 9 9 1 ) .T h e s e
studies suggest that activated immune cells can
readily penetrate the BBB. However, without
recognition of speci®c antigen targets within the
brain, the immune cells are recycled back to the
blood.
There have been several in vitro studies demon-
strating the penetration of T lymphocytes across
BMVEC (Lou et al, 1996; Joseph et al, 1997;
Adamson et al, 1999; Wong et al, 1999). In the
studies of Wong and colleagues the penetration of
lymphocytes was shown to occur both through
movement across the cytoplasm of the BMVEC and
through the tight junctions between the BMVEC.
The lymphocyte penetration occurred without any
apparent disruption of the integrity or solute
permeability of the BMVEC monolayer (Wong et
al, 1999). While the actual mechanism of penetra-
tion of immune cells across the BBB is discussed
below, it should be noted that the in vitro studies are
in agreement with the in vivo observations regard-
ing lymphocyte penetration into the brain in that
adherence and penetration is dependent on the
generalized activation state of the immune cell and
the BMVEC.
Less is known about the migration of B cells into
the CNS. Evidence that B cells do enter the brain can
be found in the studies of Hatalski et al (1998a,b)
and Knopf et al (1998). In the studies by Hatalski
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573and colleagues (1998a,b) the role of B cells in the
humoral response to Borna disease was examined.
The rats infected with Borna disease showed an
acute immune response characterized by the migra-
tion of T cells and macrophages into the sites of
infection in the CNS. There was also a chronic
i m m u n er e s p o n s ew h i c hw a so b s e r v e di nt h er a t s
infected with Borna disease. In the chronic stage,
there was, among other things, a migration of B cells
into the brain parenchyma (Hatalski et al, 1998a).
The purpose of the B cell migration in the Borna
virus infected rat was proposed to be the production
of antibody in the CNS, as the BBB was intact and
would not allow peripherally circulating antibodies
to enter into the brain (Hatalski et al, 1998b).
Similar observations have recently been made
regarding the movement of activated B cells into the
brain by Knopf and co-workers (1998). In these
studies, antigen was injected into the caudate
nucleus of naive rats and rats pre-immunized
against the antigen. Around the site of the cannula
where the antigen was injected into the brain
parenchyma of naive rats, the authors noted the
presence of a scattering of B cells, as well as other
leukocyte and lymphocyte cells (Knopf et al, 1998).
However, in the pre-immunized rats, there was a
much greater accumulation of antigen speci®c B
cells, macrophages and T cells at the injection site
within the caudate nucleus. In addition to the
immune cells detected at the injection site, anti-
bodies were also present within the CNS of the rats.
Since there was no evidence of BBB disruption, the
authors concluded that the antibodies detected in
the CNS were the result of the movement of B cells
into the brain (Knopf et al, 1998).
Importance of adhesion molecules in immune cell
traf®cking across the BBB
Identifying the cellular mechanisms by which the
BBB allows the movement of the immune cells into
the CNS is critical for understanding the immunol-
ogy of the BBB. In this regard, attention has focused
on the adhesion molecules found in the vascular
endothelial cells that form the BBB. Some of these
adhesion molecules, like the cadherins are involved
in the formation of intercellular tight junction
complexes between the brain microvessel endothe-
lial cells. Other adhesion molecules form the
selectins that are involved in the initial binding of
the leukocytes to the endothelial cells. And still
others in the integrin subclass have a role in the
secondary adhesion process and subsequent migra-
tion of the various leukocytes across the endothelial
cells. Of the three general classes of adhesion
molecules, it is alterations in the selectin and
integrin classes of adhesion molecules that most
affect penetration of leukocytes across the BBB.
Early in the study of the cell adhesion molecules,
it was suspected that the apparent selectivity with
regard to leukocyte penetration of the BBB was due
to the expression of BBB-speci®c cell adhesion
molecules. However, more likely, the selective
permeability of the BBB to the leukocytes is related,
in part, to the level of expression of the various
adhesion molecules during normal and in¯amma-
tory conditions. Immunohistochemical studies of
frozen brain tissue show minimal to non-detectable
levels of expression of various integrin adhesion
molecules, including ICAM-1, VCAM-1 and PE-
CAM-1 in the BBB (Williams et al, 1996; Washing-
ton et al, 1994; Engelhardt et al, 1994; Rossler et al,
1992). However, during activation of immune
responses in the CNS, as seen in such conditions
as MS or EAE, there is a signi®cant up-regulation of
the expression of ICAM-1, VCAM-1 and PECAM-1
in the brain microvessels (Williams et al, 1996;
Washington et al, 1994; Engelhardt et al, 1994; Bo et
al, 1996).
Studies with cultured BMVEC also indicate low
levels of expression of ICAM-1 and VCAM-1 under
normal unstimulated conditions (Lou et al, 1996;
Nottet et al, 1996; Gan et al, 1999). Furthermore,
there was a signi®cant up-regulation of ICAM-1 and
VCAM-1 expression in the cultured brain micro-
vessel endothelial cells following exposure to pro-
in¯ammatory agents or activated T cells (Lou et al,
1996; Nottet et al, 1996; Gan et al, 1999). These
studies suggest that the increased penetration of
monocytes and T cells into the central nervous
system during activated or in¯ammatory conditions
may be the result of increased expression of integrin
adhesion molecules.
Alterations in the expression of the selectin group
of adhesion molecules in the BBB during normal
and in¯ammatory conditions is less conclusive.
Studies by Egelhardt and colleagues (1997) in mice
under both normal conditions and following the
induction of EAE failed to detect the expression of
m R N Af o re i t h e rE -o rP - s e l e c t i ni nt h eb r a i n
microvessel endothelial cells. Furthermore, treat-
ment of the mice with anti E- or P-selectin
antibodies had no appreciable effect on the migra-
tion of activated T cells across the BBB (Engelhardt
et al, 1997). This suggested that E- and P-selectin
were neither constitutively expressed under normal
conditions in the BBB or induced during in¯amma-
tory conditions in which the BBB becomes perme-
able to the immune cells.
In contrast, E-selectin has been detected in
cultured human brain microvessel endothelia cells
(Lou et al, 1996; Nottet et al, 1996; Wong et al,
1999). Furthermore, exposure of human brain
microvessel endothelial cells to activated lympho-
cytes resulted in an increased expression of E-
selectin (Lou et al, 1996). Evidence for the potential
involvement of selectin adhesion molecules in the
penetration of lymphocytes in the BBB is the
observation that treatment of stimulated human
BMVEC monolayers with E-selectin antibodies
signi®cantly reduced lymphocyte migration across
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574the monolayer (Wong et al, 1999). In a different in
vitro model, the adherence of monocytes to human
brain tissue was reduced following treatment with
E-selectin antibodies (Nottet et al, 1996). Combined
treatment with both E-selectin and VCAM-1 anti-
bodies reduced monocyte adherence to brain
microvessels by greater than 70% indicating the
potential involvement of both the selectin and
integrin adhesion molecules in the adherence and
translocation of monocytes across the BBB (Nottet
et al, 1996).
In vitro studies using cultured human BMVEC
also demonstrate reduced lymphocyte penetration
following treatment with antibodies to ICAM-1,
PECAM-1 or E-selectin (Wong et al, 1999). These
studies highlighted the importance of an activated
or `primed' endothelial cell preparation, as lym-
phocyte adherence and penetration across unacti-
vated human BMVEC monolayers was minimal.
Interestingly, while adherence of T cells to TNF-
activated BMVEC monolayers was dependent in
part to VCAM-1, antibodies to VCAM-1 did not
effect the migration of the lymphocytes across the
monolayers (Wong et al, 1999).
Perhaps the most convincing evidence for the
selectins involvement in the translocation of the
immune cells across the BBB are the studies in
selectin knock-out mice (Tang et al, 1996). In these
studies, mice genetically de®cient in P-selectin, or
both P- and E-selectin were examined for their
susceptibility to acute cytokine-induced meningi-
tis. In these studies, the control mice treated with
the cytokine developed severe meningeal in¯am-
mation that was characterized by signi®cant in-
creases in leukocyte accumulation in the central
nervous system and enhanced BBB permeability
(Tang et al, 1996). However, in the P-selectin knock-
out mice, leukocyte in®ltration in the CNS and BBB
permeability were signi®cantly inhibited. Further-
more, in the doubly de®cient P- and E-selectin mice,
there was a nearly complete inhibition of leukocyte
migration and BBB permeability (Tang et al, 1996).
These studies suggest that the selectins do have a
role in the increased penetration of immune cells in
the CNS observed following in¯ammatory events in
the brain.
While it is apparent that adhesion molecules
have a major role in the margination and
diapedesis of immune cells across the BMVEC,
little is know about the second messenger systems
that may be activated to facilitate the penetration
of the immune cells across the BBB. In this regard,
the studies of Adamson et al (1999) have shed
light on cellular events which occur as a result of
binding of lymphocytes to ICAM expressed in the
BMVEC. By cross-linking the ICAM-1 expressed
on an immortalized rat brain endothelial cell line
with IgG directed at anti-ICAM-1 antibodies,
Adamson and colleagues were able to demonstrate
a clustering of ICAM-1 and an increase in actin
stress ®ber formation in the BMVEC. The stress
®ber formation was associated with the activation
of the small guanosine triphosphate-binding pro-
tein, Rho, suggesting that the Rho signalling
p a t h w a yw a si n v o l v e di nI C A M - 1m e d i a t e d
lymphocyte migration in the BBB. Further evi-
dence for activation of Rho in the BMVEC for
penetration of the immune cells is the experiments
performed in the presence of the Rho inhibitor, C3
transferase. While activated T lymphocytes were
still able to adhere to the BMVEC monolayers,
treatment with C3 transferase signi®cantly re-
duced the migration of the lymphocytes across
the monolayer, the formation actin stress ®bers,
and the accumulation of Rho in the cells
(Adamson et al, 1999). These studies indicate that
the adhesion molecules, such as ICAM-1, not only
bind to the lymphocytes as they travel through the
bloodstream, but also activate the endothelial cell
through various signalling pathways to facilitate
migration of the lymphocytes across the BBB.
Role of the blood-brain barrier as an immune
response modi®er
It is clear that the brain endothelial cells are
affected by a number of different pro-in¯ammatory
mediators such as cytokines, prostaglandins, and
bradykinin. In many cases, these pro-in¯ammatory
agents have an important role in initiating the
changes in the permeability or adhesion properties
of the endothelial cells that allow the immune cells
to in®ltrate the CNS. However, in addition to their
effects on BBB permeability, activation of the brain
microvessel endothelial cells by various pro-in¯am-
matory agents may serve other purposes important
to the immune response.
Evidence for the BBB to act as an immune
response modi®er is illustrated in the studies of
Quan et al (1997) and Herkenham et al (1998) in
which the temporal expression of intracellular
markers of cellular activation was examined follow-
ing peripheral administration of either lipopolysac-
charide or interleukin-1, respectively. In both these
studies, there was a time dependent response to the
pro-in¯ammatory agents, with increased expression
of c-fos and inhibitory factor kappabalpha ®rst
observed (within 30±60 min) in the barrier cells
of the choriod plexus and blood-brain barrier, and
circumventricular organs that are not protected by
the BBB (Quan et al, 1997; Herkenham et al, 1998).
Interestingly, following the initial burst in activity
observed in the brain microvasculature, the micro-
vessel endothelial cells returned to their quiescent
state, and a delayed increase in activity was
observed in the cells within the CNS that were
adjacent to the BBB. The temporal cellular activa-
tion pattern observed, prompted the authors to
suggest that peripheral immune response modi®ers
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mediators released from the cells of the BBB and
blood-cerebral spinal ¯uid barrier.
In considering the identify of the secondary
immune response modulators released from the
brain microvessel endothelial cells there are a
multitude of potential candidates. The vascular
endothelium expresses several different cytokine
and cytokine receptors. The demonstration that
exposure of human brain microvessel endothelial
cell monolayers to stimulated T lymphocytes
results in the secretion of interleukin 6 and
interleukin 8 from the endothelial cells supports
the contention that cytokines released from the BBB
may act as secondary immune response modulators
(Lou et al, 1996). The cytokines released from the
brain endothelial cells may act to modulate activity
of themselves or other nearby cells such as the
astrocytes and glial cells. Other potential immune
modulators released by the endothelial cells of the
BBB are arachidonic acid metabolites such as
prostaglandins and thromboxanes. Support for the
possible involvement of the prostaglandins is the
studies by Quan and coworkers (1998) that demon-
strated an induction in cyclooxygenase 2, one of the
isoenzymes involved in prostaglandin production,
in brain microvessel endothelial cells several hours
after exposure to bacterial LPS or cytokines. A
similar induction of cyclooxygenase 2 with a
resulting increased release of prostaglandin E, has
been observed in our laboratory in primary cultured
bovine brain microvessel endothelial cell mono-
layers following treatment with tumor necrosis
factor (manuscript in preparation).
The concept of the BBB acting as a relay point for
either amplifying or dampening immune responses
in the brain is an area that is underdeveloped. Most
attention has focused on the role of the BBB in
allowing the penetration of immune cells into the
CNS. While immune cell traf®cking across the BBB
is an important event, the BMVEC that form the BBB
also have the ability, through increased perme-
ability, altered release, or cell-to-cell junctional
communication, to control the immuno-responsive-
ness of the brain.
Summary
The BMVEC forming the BBB have an important
role in mediating immune responses in the central
nervous system. Given the anatomical location of
the brain microvessel endothelial cells, they repre-
sent a point of passage for immune cells from the
systemic blood into the extracellular environment
of the brain. While normal traf®cking of the
immune cells across the BBB is limited, under the
appropriate conditions, the brain microvessel en-
dothelial cells can allow the selective entry of
leukocytes into the central nervous system. Char-
acterization of the stimuli required to produce the
change in BBB permeability to the cells of the
immune system and the cellular factors involved in
such changes are areas of intense examination. Both
in vivo and in vitro studies suggest the increased
passage of immune cells across the BBB during
in¯ammatory conditions involve changes in the
expression of adhesion molecules in the endothelial
cells that form the BBB. The presence of various
chemokines may also contribute to the permeability
of the BBB to select leukocytes observed during
in¯ammatory conditions.
The brain microvessel endothelial cells also act
as an immune response modi®er, releasing agents
that in turn act upon cells within the central
nervous system. One important target of these
agents released from the brain microvessel endothe-
lial cells is the microglia. The importance of this can
not be overlooked as modi®cation of the activity of
the microglial cells, the resident monocytes of the
central nervous system, would be expected to play
an important role in immune responses in the brain.
In this regard, the release of endogenous immune
response modi®ers (i.e. cytokines, prostaglandins,
etc) by the endothelial cells in the BBB may act to
either intensify or inhibit the propagation of the
immune response in the brain.
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